Enzalutamida en este contexto (CPRC): ¿cuáles son los pacientes? - page 21

Risk for a clinically meaningful deterioration in FACT-P total
and PCS scores
Nussbaum N et al. Presented at ISPOR 20
th
Annual Meeting, Philadelphia, PA, USA, May 2015. Presentation PCN126.
1...,11,12,13,14,15,16,17,18,19,20 22,23,24,25,26,27,28,29,30,31,...42
Powered by FlippingBook